Effects of various antihistamines on oxotremorine-induced hypothermia in mice.
D000480:Alkynes / Q000037:antagonists & inhibitors; D000704:Analysis of Variance; D000818:Animals; D001285:Atropine / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000627:therapeutic use; D002744:Chlorpheniramine / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D005029:Ethylenediamines / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D007035:Hypothermia / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010277:Parasympathomimetics / Q000037:antagonists & inhibitors; D010879:Piperazines / Q000627:therapeutic use; D011398:Promethazine / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011759:Pyrrolidines / Q000037:antagonists & inhibitors; D011760:Pyrrolidinones / Q000037:antagonists & inhibitors; D014309:Tripelennamine / Q000627:therapeutic use
D000480:Alkynes; D001593:Benzyl Compounds; D005029:Ethylenediamines; D006634:Histamine H1 Antagonists; D010277:Parasympathomimetics; D010879:Piperazines; D011725:Pyridines; D011759:Pyrrolidines; D011760:Pyrrolidinones; D003533:Cyproheptadine; D014309:Tripelennamine; D002744:Chlorpheniramine; D001285:Atropine; D004155:Diphenhydramine; D011398:Promethazine